CAS: 878385-84-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | AZD-5069 REF: IN-DA01ENV8CAS: 878385-84-3 | 98% | To inquire | Tue 07 Jan 25 |
 | AZD5069 REF: 54-BISN0063CAS: 878385-84-3 | 98% | 51.00 € | Tue 07 Jan 25 |
 | AZD-5069 REF: TM-T7681CAS: 878385-84-3 | 98.53% - 98.85% | 50.00 €~1,111.00 € | Mon 13 Jan 25 |
 | AZD5069 REF: 3D-DKB38584CAS: 878385-84-3 | Min. 95% | 136.00 €~569.00 € | Mon 03 Mar 25 |
 | AZD-5069 REF: TR-A965309CAS: 878385-84-3 | - - - | - - - | Discontinued product |
AZD-5069
CAS:878385-84-3
Formula:
C18H22F2N4O5S2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
476.5179
Ref: IN-DA01ENV8
| 10mg | 72.00 € | ||
| 25mg | 114.00 € | ||
| 50mg | 192.00 € | ||
| 100mg | 232.00 € | ||
| 250mg | 584.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 54-BISN0063
| 1mg | 51.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
AZD-5069
CAS:878385-84-3
AZD-5069 is an chemokine receptor 2 antagonist (CXCR2; IC50 = 0.79 nM).
Formula:
C18H22F2N4O5S2
Purity:
98.53% - 98.85%
Color and Shape:
Solid
Molecular weight:
476.52
Ref: TM-T7681
| 1mg | 50.00 € | ||
| 2mg | 64.00 € | ||
| 5mg | 83.00 € | ||
| 10mg | 122.00 € | ||
| 25mg | 224.00 € | ||
| 50mg | 344.00 € | ||
| 100mg | 513.00 € | ||
| 500mg | 1,111.00 € | ||
| 1mL*10mM (DMSO) | 88.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
AZD5069
CAS:878385-84-3
AZD5069 is a molecule that has been shown to have potent inducers of chemokine production, …
Formula:
C18H22F2N4O5S2
Purity:
Min. 95%
Molecular weight:
476.52 g/mol
Ref: 3D-DKB38584
| 2mg | 136.00 € | ||
| 5mg | 189.00 € | ||
| 10mg | 273.00 € | ||
| 25mg | 400.00 € | ||
| 50mg | 569.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025
AZD-5069
CAS:878385-84-3
Formula:
C18H22F2N4O5S2
Color and Shape:
White to Off-White Solid
Molecular weight:
476.52
Ref: TR-A965309
| 1mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information |
